今开:0.0 | 昨收:0.2077 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:4601759.0 |
赛托瑞疗法(CYTX)2019-08-15 11:50
$赛托瑞疗法(CYTX)$ NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB Filed: 2019-08-14 AccNo: 0001564590-19-032183 Size: 63 KB 网页链接查看全文
赛托瑞疗法(CYTX)2019-08-10 05:10
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-09 AccNo: 0001564590-19-031278 Size: 32 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接查看全文
赛托瑞疗法(CYTX)2019-08-03 04:15
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001564590-19-028357 Size: 35 KBItem 7.01: Regulation FD Disclosure 网页链接查看全文
赛托瑞疗法(CYTX)2019-08-16 05:40
$赛托瑞疗法(CYTX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-15 AccNo: 0001564590-19-032349 Size: 6 MB 网页链接查看全文
赛托瑞疗法(CYTX)2019-07-29 20:20
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001564590-19-026454 Size: 249 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接查看全文
赛托瑞疗法(CYTX)2019-08-06 20:15
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001564590-19-028996 Size: 53 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接查看全文
赛托瑞疗法(CYTX)2019-07-23 20:20
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-23 AccNo: 0001564590-19-025505 Size: 37 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接查看全文
赛托瑞疗法(CYTX)2019-06-28 06:10
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-06-27 AccNo: 0001564590-19-023871 Size: 39 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接查看全文
AutoRfg2015-04-24 09:20
$赛托瑞医疗(CYTX)$ Cytori Therapeutics Inc is estimated to report earnings on 05/11/2015. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, o...查看全文
AutoRfg2015-04-24 01:23
$赛托瑞医疗(CYTX)$ 3位分析师12个月目标价是4到6块。并不一定要那么乐观。但我想说如果你不急着用现金,就继续拿着吧。另外一篇分析的链接:网页链接查看全文
用户16968303892015-04-23 23:27
$赛托瑞医疗(CYTX)$如果有一个公司但凡有点股价不正常波动都有管理层出来告诉大家到底怎么了,一旦有任何利空就有管理层强势回应,这样的股票值得长期持有。希望大瑞是下一个$阿里巴巴(BABA)$一样持有几年翻数倍的票查看全文
$赛托瑞疗法(CYTX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-15 AccNo: 0001564590-19-032349 Size: 6 MB 网页链接
$赛托瑞疗法(CYTX)$ NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB Filed: 2019-08-14 AccNo: 0001564590-19-032183 Size: 63 KB 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-09 AccNo: 0001564590-19-031278 Size: 32 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001564590-19-028996 Size: 53 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001564590-19-028357 Size: 35 KBItem 7.01: Regulation FD Disclosure 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001564590-19-026454 Size: 249 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-23 AccNo: 0001564590-19-025505 Size: 37 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-16 AccNo: 0001564590-19-025075 Size: 57 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-11 AccNo: 0001564590-19-024844 Size: 64 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission o...
$赛托瑞疗法(CYTX)$ 8-K - Current report Filed: 2019-07-05 AccNo: 0001564590-19-024571 Size: 40 KBItem 2.05: Cost Associated with Exit or Disposal ActivitiesItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensat...